Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.54

+3.2%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (20784)	5/14/1998 3:36:00 PM
From: Pseudo Biologist	Read Replies (1) of 32384

Henry, you may be interested to know that Novartis drug Simulect was given formal approval by the FDA as per today's issue of "BioWorld." As discussed here, Seragen will receive royalties on sales of this product. From the 10-K of Seragen's, it appears that these royalty payments will amount to 0.75% (not clear if of gross or net sales?) and will begin in 2001. Here is a link to the news: biz.yahoo.com Sorry to be sort of "on-topic" -gg- PB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next